Q2, 2011
The pharmaceutical industry has typically been slow to adopt new data collection technology when it comes to clinical development. And to some degree this is understandable when you are working in a highly regulated industry where patient safety is the highest priority. Why change a proven process?
However, over the past decade we have witnessed the industry's almost total acceptance of electronic data capture (EDC) technology and the growing acceptance of electronic patient reported outcomes (ePRO) applications.
Respondents provided their satisfaction with product attributes like human-machine interface, technical support, EDC page load speed, ePRO reporting portal, and integration capabilities, just to name a few. You may be surprised to find that providers that rate high on brand familiarity and use are not necessarily those that garner the highest satisfaction ratings.
Report Content: This report contains the following four sections.
1. High-level takeaways and implications - In this section we lay out what the data in this report is telling us and how it could impact your development strategies and operations. The goal of this section is to arm you with usable recommendations that can impact your current and future operations.
2. EDC service provider section – This section focuses on how Principal Investigators and Site Coordinators view the various aspects and market dynamics as they relate to Electronic Data Capture. These include:
Adoption and preference for EDC
Service provider brand leadership and performance
3. ePRO service provider section – This section focuses on how Principal Investigators and Site Coordinators view the various aspects and market dynamics as they relate to Electronic Patient Reported Outcomes. These include:
Adoption and preference for ePRO
Service provider brand leadership and performance
4. Trends and ideas impacting clinical development – In the end a sponsor or service provider wants to lock patient data on-time. This section ties together respondents’ views of how these technologies can and could improve the speed of and general conduct of clinical development studies.
As always, an appendix of Charts and Graphs is also included within this report with responses to all questions asked in this study.
What Readers Will Learn From This Report:
Sponsors and CROs
How to select a technology partner that enhances your relationships with sites
Preferences for specific EDC and ePRO applications
What study types users believe are least suited for the technologies
Current and future adoption estimates for ePRO
Which technology providers have the best and worst integration capabilities with other technologies
Technology Providers
Their own brand's strength vs. competing providers
Product adoption profiles for all major brands
Detailed performance profiles for all major technology providers across critical success factors
Competitive strengths and weaknesses
Product satisfaction profiles across all major brands
Technology users' brand preferences
EDC Vendors Profiled:
DSG
DataLabs
DATATRAK
Etrials/Merge Healthcare
Medidata Rave
Oracle Remote Data Capture (RDC)
Phase Forward InForm
Phoenix Data Systems
ePRO Vendors Profiled:
Almac
Arrowhead
CRF Inc
ERT
ICOPhone
Invivodata
PHT
Symfo
Other Measurements Reported:
Human-machine Interface
Query Process
Speed/ Page Loads
Technical Support
Integration Capabilities
Overall Satisfaction
Copyright and Usage Guidelines 7
Introduction 8
Study Findings 11
High-level takeaways and implications 12
Sponsor and CRO organizations 12
EDC organizations 13
ePRO organizations 14
Electronic Data Capture (EDC) 16
EDC Market Dynamics 16
Preference for EDC vs. paper CRFs 16
Negative associations with EDC 17
EDC systems on-site 18
Study suitability for EDC 18
EDC Brand Leadership 19
Brand familiarity 19
EDC provider use 20
EDC provider preference 21
EDC Platform Performance and Satisfaction 22
Satisfaction with product attributes 22
Improving performance and features 24
EDC Integration with IVR & ePRO technologies 25
EDC Section Conclusions 27
Electronic Patient Reported Outcomes (ePRO) 28
ePRO Market Dynamics 28
Preference for ePRO vs. paper diaries 28
ePRO systems currently in use 29
Study suitability for ePRO 29
Negative associations with ePRO 30
ePRO Brand Leadership 31
ePRO Brand familiarity 31
ePRO service provider use 32
ePRO provider preference 33
ePRO Platform Performance and Satisfaction 34
Satisfaction with product attributes 35
Integration with IVR & EDC technologies 38
Improving performance and features 39
ePRO Section Conclusions 40
Trends impacting clinical development 41
Reducing the length of a clinical trial 41
Impact on Reducing Clinical Trial Time -EDC 41
Impact on Reducing Clinical Trial Time -ePRO 42
ePRO Usage: Present and Future 44
Trends impacting clinical development Section Conclusions 45